Pharma Prescription Transportation 
World of DTC Marketing
JANUARY 4, 2022
transportation), and indirect expenses (e.g., These cost estimates include cancer-attributable costs for medical services and oral prescription drugs. Pharma companies are aware that insurers will rarely say no to new cancer therapies, but increased scrutinization of early approvals is on the horizon. lost work and income).
Pharmaceutical Technology
MARCH 3, 2023
French biopharmaceutical firm Ipsen has concluded the purchase of US-based Albireo Pharma , expanding its rare disease portfolio. Albireo’s pipeline includes its lead asset, Bylvay (odevixibat), a potent, once-a-day, oral, non-systemic, ileal bile acid transport inhibitor (IBATi).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
DECEMBER 15, 2022
They requested recognition that the prescription medicines sector is critical in the EU and that national emergency plans for gas/oil supplies should apply, reducing the complexity and cost of regulatory compliance and reform of medicines procurement and pricing models. Raw materials, transport, fuel, and energy have all increased in price.
Pharmaceutical Technology
SEPTEMBER 7, 2022
Prescription refill and generic drug programmes. Prescription collection lockers. Integrating AI into the operations of retail pharmacies helps in improving the decision-making process, order fulfilment, demand forecasting, and monitoring of the transportation and storage environment. Speciality care. Compounding services.
Pharmaceutical Technology
SEPTEMBER 5, 2022
The list includes companies that offer various products and services, including but not limited to: · Wholesaling and distribution of prescription drugs, supplement drugs, over-the-counter (OTC) medicines, antiseptics, antibiotics, and other product types · End formulation contracts. · GDP and GMP advisory. Warehousing and logistics services.
PM360
AUGUST 9, 2022
The industry has been limited in its ability to implement creative solutions to engage and motivate patients because the FDA has strict guidelines for what pharma companies can communicate with patients. Yet, pharma companies spend more than $5 billion on patient support programs every year, and only 3% of patients are using them.
pharmaphorum
DECEMBER 18, 2022
The clerical overhead of enrolment forms navigated over fax and phone calls fails to deliver on the promise, resulting in lower-than-expected prescription volumes and lacklustre adoption among prescribers. Technology is upending every aspect of our lives, from retail to transportation. Unfulfilled promise of technology.
Expert insights. Personalized for you.
273 
Let's personalize your content